Efficacy of Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux

被引：5

作者：

Usmani, Saad Z. ^{[1
]}

Dimopoulos, Meletios A. ^{[2
]}

Belch, Andrew ^{[3
]}

White, Darrell ^{[4
]}

Benboubker, Lofti ^{[5
]}

Cook, Gordon ^{[6
,7
]}

Leiba, Merav ^{[8
]}

Morton, James ^{[9
]}

Ho, P. Joy ^{[10
]}

Kim, Kihyun ^{[11
]}

Takezako, Naoki ^{[12
]}

Khokhar, Nushmia Z. ^{[13
]}

Guckert, Mary ^{[13
]}

Wu, Kaida ^{[13
]}

Qin, Xiang ^{[13
]}

Casneuf, Tineke ^{[14
]}

Chiu, Christopher ^{[13
]}

Sasser, A. Kate ^{[13
]}

San-Miguel, Jesus ^{[15
]}

机构：

[1] Levine Canc Inst Carolinas HealthCare Syst, Charlotte, NC USA

[2] Univ Athens, Athens, Greece

[3] Univ Alberta Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada

[4] Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada

[5] Ctr Hosp Regional Univ CHRU, Serv Hematol & Therapie Cellulaire, Hop Bretonneau, Tours, France

[6] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Leeds, W Yorkshire, England

[7] Univ Leeds, Leeds, W Yorkshire, England

[8] Sheba Med Ctr, Tel Hashomer, Israel

[9] Icon Canc Care, South Brisbane, Qld, Australia

[10] Royal Prince Alfred Hosp, Inst Haematol, Camperdown, NSW, Australia

[11] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea

[12] Natl Hosp Org Disaster Med Ctr Japan, Dept Hematol, Tachikawa, Tokyo, Japan

[13] Janssen Res & Dev, LLC, Spring House, PA USA

[14] Janssen Res & Dev, Beerse, Belgium

[15] Clin Univ Navarra CIMA, IDISNA, Pamplona, Spain

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.1151.1151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1151

引用

页数：7

共 50 条

[1] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Dimopoulos, Meletios A.
San-Miguel, Jesus
Belch, Andrew
White, Darrell
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Kaufman, Jonathan L.
Sutherland, Heather J.
Lalancette, Marc
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Prince, H. Miles
Cochrane, Tara
Oriol, Albert
Bahlis, Nizar J.
Chari, Ajai
O'Rourke, Lisa
Wu, Kaida
Schecter, Jordan M.
Casneuf, Tineke
Chiu, Christopher
Soong, David
Sasser, A. Kate
Khokhar, Nushmia Z.
Avet-Loiseau, Herve
Usmani, Saad Z.
HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096
[2] Efficacy of Daratumumab, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Among Patients with 1 to 3 Prior Lines of Therapy Based on Previous Treatment Exposure: Updated Analysis of Pollux
Moreau, Philippe
Kaufman, Jonathan L.
Sutherland, Heather J.
Lalancette, Marc
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Prince, Miles
Cochrane, Tara
Khokhar, Nushmia Z.
Guckert, Mary
Qin, Xiang
Oriol, Albert
BLOOD, 2016, 128 (22)
[3] UPDATED EFFICACY AND SAFETY ANALYSIS OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRd) VERSUS LENALIDOMIDE AND DEXAMETHASONE (Rd) FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM; POLLUX)
Moreau, P.
White, D.
Benboubker, L.
Cook, G.
Leiba, M.
Morton, J.
Ho, P. J.
Kim, K.
Takezako, N.
Trivedi, S.
Wu, K.
Casneuf, T.
Chiu, C.
Schecter, J. M.
Dimopoulos, M. A.
HAEMATOLOGICA, 2018, 103 : 31 - 31
[4] Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Pollux
Dimopoulos, Meletios A.
White, Darrell J.
Benboubker, Lofti
Cook, Gordon
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Trivedi, Sonali
Wu, Kaida
Casneuf, Tineke
Chiu, Christopher
Schecter, Jordan
Moreau, Philippe
BLOOD, 2017, 130
[5] EFFICACY AND SAFETY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS RD ALONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: UPDATED ANALYSIS OF POLLUX
Dimopoulos, M. A.
Moreau, P.
Nahi, H.
Plesner, T.
Goldschmidt, H.
Suzuki, K.
Orlowski, R. Z.
Rabin, N.
Leiba, M.
Oriol, A.
Chari, A.
San-Miguel, J.
Richardson, P. G.
Usmani, S. Z.
O'Rourke, L.
Wu, K.
Casneuf, T.
Chiu, C.
Qin, X.
Bahlis, N. J.
HAEMATOLOGICA, 2017, 102 : 108 - 109
[6] Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
Jonathan L. Kaufman
Meletios A. Dimopoulos
Darrell White
Lotfi Benboubker
Gordon Cook
Merav Leiba
James Morton
P. Joy Ho
Kihyun Kim
Naoki Takezako
Philippe Moreau
Heather J. Sutherland
Hila Magen
Shinsuke Iida
Jin Seok Kim
H. Miles Prince
Tara Cochrane
Albert Oriol
Nizar J. Bahlis
Ajai Chari
Lisa O’Rourke
Sonali Trivedi
Tineke Casneuf
Maria Krevvata
Jon Ukropec
Rachel Kobos
Hervé Avet-Loiseau
Saad Z. Usmani
Jesus San-Miguel
Blood Cancer Journal, 10
[7] Daratumumab, lenalidomide, and dexamethasone (DRd) vs lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): Efficacy and safety update (POLLUX).
Bahlis, Nizar J.
Moreau, Philippe
Nahi, Hareth
Plesner, Torben
Goldschmidt, Hartmut
Suzuki, Kenshi
Orlowski, Robert Z.
Rabin, Neil
Leiba, Merav
Oriol, Albert
Chari, Ajai
Miguel, Jesus San
Richardson, Paul G.
Usmani, Saad Zafar
O'Rourke, Lisa Marie
Wu, Kaida
Casneuf, Tineke
Chiu, Christopher
Qin, Xiang
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8] Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
Kaufman, Jonathan L.
Dimopoulos, Meletios A.
White, Darrell
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Morton, James
Joy Ho, P.
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Sutherland, Heather J.
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Miles Prince, H.
Cochrane, Tara
Oriol, Albert
Bahlis, Nizar J.
Chari, Ajai
O'Rourke, Lisa
Trivedi, Sonali
Casneuf, Tineke
Krevvata, Maria
Ukropec, Jon
Kobos, Rachel
Avet-Loiseau, Herve
Usmani, Saad Z.
San-Miguel, Jesus
BLOOD CANCER JOURNAL, 2020, 10 (11)
[9] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
Plesner, Torben
Arkenau, Hendrik-Tobias
Lokhorst, Henk M.
Gimsing, Peter
Krejcik, Jakub
Lemech, Charlotte
Minnema, Monique C.
Lassen, Ulrik
Laubach, Jacob P.
Ahmadi, Tahamtan
Yeh, Howard
Guckert, Mary E.
Feng, Huaibao
Brun, Nikolai Constantin
Lisby, Steen
Basse, Linda
Palumbo, Antonio
Richardson, Paul G.
BLOOD, 2014, 124 (21)
[10] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
Plesner, T.
Arkenau, H. T.
Lokhorst, H. M.
Gimsing, P.
Krejcik, J.
Lemech, C.
Minnema, M. C.
Lassen, U.
Ahmadi, T.
Yeh, H.
Guckert, M.
Brun, N. C.
Lisby, S.
Basse, L.
Palumbo, A.
Richardson, P. G.
HAEMATOLOGICA, 2014, 99 : 104 - 104

← 1 2 3 4 5 →